CTLA4 and cutaneous melanoma: In addition, immune checkpoint inhibitors, such as programmed cell death 1 (PD-1) and cytotoxic T lymphocyte antigen-4 (CTLA-4) inhibitors, have been successfully used in advanced cutaneous melanoma and may be effective against CM.